Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

US Congress Members Allege GenScript Controlled by China Communist Party

publication date: Jun 3, 2024

GenScript Biotechnology may be the next target of the US Congress, as part of its ongoing examination into biopharmas with links to China. Founded in 2002 in New Jersey, GenScript offers a broad array of early biologic services to biopharmas and researchers. Its three founders are all from China, and the company has expanded into China. Two members of the US House of Representatives Committee on China asked the US intelligence community to determine if China’s Chinese Communist Party  influences GenScript's operations. The letter to the FBI included a strong allegation: “GenScript is working to establish CCP-controlled chokepoints in critical areas of biotechnology in which the US currently leads,” it said. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital